<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02681939</url>
  </required_header>
  <id_info>
    <org_study_id>T/IM-NF/Physio/15/04</org_study_id>
    <nct_id>NCT02681939</nct_id>
  </id_info>
  <brief_title>Effect of Tulsi (Ocimum Sanctum) on Biochemical Parameters in Young Overweight and Obese Subjects</brief_title>
  <official_title>Effect of Supplementation of Tulsi (Ocimum Sanctum Linn.) on Metabolic Parameters and Liver Enzymes in Young Overweight and Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, Bhubaneswar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, Bhubaneswar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to investigate the effect of Tulsi (Ocimum sanctum Linn.) on metabolic and
      biochemical parameters in young overweight and obese subjects. Thirty overweight/obese
      volunteers will be divided into two groups. The first group will receive no intervention. The
      second group will be supplemented with one capsule of Tulsi orally every morning and evening
      in empty stomach for 60 days. The metabolic parameters and liver enzymes will be evaluated
      before and after the intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, parallel group, open label pilot study to investigate the effect of
      Tulsi (Ocimum sanctum Linn.) on metabolic and biochemical parameters in young overweight and
      obese subjects. Thirty overweight/obese volunteers will be divided into two groups. The first
      group will receive no intervention. The second group will be supplemented with one capsule of
      Tulsi orally every morning and evening in empty stomach for 60 days. The metabolic parameters
      and liver enzymes will be evaluated before and after the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum lipid profile</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma glucose</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma insulin</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum liver enzymes</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>60 days</time_frame>
    <description>Using homeostatic model assessment(HOMA2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Tulsi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One capsule of Tulsi (Ocimum sanctum) orally, every morning and evening in empty stomach for 60 days regularly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Tulsi</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tulsi(Ocimum sanctum Linn.) capsules</intervention_name>
    <arm_group_label>Tulsi</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight/obese volunteers of both genders from age 17 to 30 years

        Exclusion Criteria:

          -  Addiction to tobacco and/or alcohol.

          -  Not on drugs like fluoroquinolones, anticonvulsants, antihypertensives,
             corticosteroids, hormonal contraceptives, hypolipidemic agents, anti psychotics,
             protease inhibitors and isotretinoin.

          -  Not suffering from liver disease, malabsorption, nephrotic syndrome, thyroid disorder,
             allergy or any other chronic disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sushil Ch Mahapatra, MBBS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>All India Institute of Medical Sciences, Bhubaneswar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences, Bhubaneswar</name>
      <address>
        <city>Bhubaneswar</city>
        <state>Odisha</state>
        <zip>751019</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2016</study_first_submitted>
  <study_first_submitted_qc>February 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2016</study_first_posted>
  <last_update_submitted>April 18, 2016</last_update_submitted>
  <last_update_submitted_qc>April 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, Bhubaneswar</investigator_affiliation>
    <investigator_full_name>Dr. Sushil Chandra Mahapatra</investigator_full_name>
    <investigator_title>Professor and Head, Department of Physiology, All India Institute of Medical Sciences, Bhubaneswar</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

